Robert Gabbay, MD, PhD, delineates key differences between type 1 and type 2 diabetes, including autoimmune antibodies, insulin resistance, and insulin deficiency.
Projected Burden Demands Investment and Equity in Type 1 Diabetes Care
Global type 1 diabetes cases are on the rise, especially in low-income countries, highlighting an urgent need for targeted health care strategies and epidemiological studies.
Read More
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Listen
Gaps in the Coordination of Care for Older Adults With or at Risk for Cardiovascular Disease
Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
FIT Outperforms Blood-Based cfDNA Test in Detecting Precancerous Colorectal Lesions
Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal lesions, a comparative study found.
Combining Bone Health, Function Scores Refines MG Fracture Prediction
Combining FRAX and MG-ADL assessments enhances fracture risk prediction in patients with myasthenia gravis (MG), guiding targeted interventions for better outcomes.